ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
A study of a copper enzyme that misfolds and malfunctions in copper- and iron-metabolism diseases indicates that it can't be fixed simply by inducing the copper-deficient misfolded version to take up more copper (Biochemistry, DOI: 10.1021/bi700715e). Ceruloplasmin, an oxidase normally containing six copper atoms, lacks copper and therefore misfolds in disorders such as Wilson's disease, aceruloplasminemia, and anemia. Researchers speculated that these diseases could be treated by supplying copper, which might be taken up by the enzyme and permit it to refold properly. However, a chemical unfolding study of the enzyme by Erik Sedlak and Pernilla Wittung-Stafshede of Rice University now suggests that copper-free ceruloplasmin adopts an irretrievably misfolded globular structure in cells and that the related diseases can be treated only by inducing ceruloplasmin to take up copper when it is first biosynthesized, not after it has already misfolded. The findings "may facilitate new approaches to incorporate copper into copper-lacking ceruloplasmin variants found in affected patients," the researchers note.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X